FdaApplication
BLA 125858
Identifiers
- fda_app_no: BLA125858
Properties
| Property | Value |
|---|---|
| applicant_name | Ultragenyx Pharmaceutical, Inc. |
| application_type | BLA |
| approval_date | 2026-08-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GENGLYCOS | — | 3x10^13VG/ML | Suspension |
1 product